To ask the Secretary of State for Health and Social Care, what plans his Department has to monitor the effectiveness of existing covid-19 vaccines against new variants of the SARS-CoV-2 virus.
To ask the Secretary of State for Health and Social Care, what plans he has to monitor the effectiveness of existing covid-19 vaccines against new variants of the SARS-CoV-2 virus.
Public Health England has published early estimates of vaccine effectiveness which includes the United Kingdom variant of concern which is available at the following link:
The 2021 Budget included £28 million to increase the United Kingdom’s capacity for vaccine testing, support for clinical trials and improve the UK’s ability to rapidly acquire samples of new variants of COVID-19. In addition, £22 million has been allocated to a world-leading study to test the effectiveness of combinations of different vaccines and fund the world’s first study assessing the effectiveness of a third dose of vaccine to improve the response against current and future variants of COVID-19. A further £5 million investment in clinical-scale mRNA manufacturing has been provided to create a ‘library’ of vaccines to work against COVID-19 variants for possible rapid response deployment.